F1000Prime Recommendation of Use of Anastrozole for Breast Cancer Prevention (IBIS-II): Long-Term Results of a Randomised Controlled Trial.
doi 10.3410/f.737097922.793571883
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2020
Authors
Publisher
Faculty Opinions Ltd